Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Molecular Profile||Indication/Tumor Type||Response Type||Relevant Treatment Approaches||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|MAP2K1 Q56P MAP2K1 H119Y MAP2K1 D351G||colorectal cancer||predicted - sensitive||LY3214996||Preclinical - Cell line xenograft||Actionable||In a preclinical study, LY3214996 treatment in a colorectal cancer cell line harboring MAP2K1 Q56P, MAP2K1 H119Y, and MAP2K1 D351G led to decreased cell proliferation in culture, and inhibition of tumor growth in a cell line xenograft model (PMID: 31744895).||31744895|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|